Alzex Neuropharma Inc. (TRRI)
Alzex Neuropharma Inc. operates in the Other Precious Metals industry of the Basic Materials sector, headquartered in Las Vegas, NV, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $1,054. On trailing twelve-month figures it carries a trailing P/E of -0.01, a net margin of 0.0%. Its beta of -4.12 implies it has historically moved less than the broad market.
Alzex Neuropharma Inc. is a development-stage biopharmaceutical company developing therapeutics for Alzheimer's disease and other neurological disorders, based on assets and intellectual property acquired from Alzex Biomedical Group Inc. in 2022. Formerly known as Trinity Resources Inc., a mineral exploration company, it adopted its current name in December 2022. The company is based in Henderson, Nevada.
Alzex Neuropharma Inc. is most often compared with the following Basic Materials names: